The presence of gene amplification was determined in 66 fresh head-and-neck SCC specimens using a battery of 9 different probes. Amplification of at least one gene was found in I 2 samples (18%), of which 7 were amplified at multiple loci (58%). We observed amplifications for EGFR (10% of samples) a
Identification of Genes Overexpressed in Head and Neck Squamous Cell Carcinoma Using a Combination of Complementary DNA Subtraction and Microarray Analysis
β Scribed by Douglas B. Villaret; Tongtong Wang; Davin Dillon; Jiangchun Xu; Dhileep Sivam; Martin A. Cheever; Steven G. Reed
- Book ID
- 110082253
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 571 KB
- Volume
- 110
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Resistance to cisplatin is a major obstacle to successful treatment of head and neck squamous cell carcinoma (HNSCC). To investigate the molecular mechanism of this resistance, we compared the gene expression profiles between the cisplatinβsensitive SCC cell lines (Saβ3, Hβ1 and KB) and
## Loss of heterozygosity (LOH ) at chromosome band 10q23 occurs frequently in a wide variety of human tumors. A recently identified candidate tumor suppressor gene, PTEN located on 10q23, is mutated in multiple advanced cancers. To explore whether PTEN is associated with human squamous cell carci
## Abstract The degree of gene amplification for epidermal growth factor receptor (EGFR) and its expression levels were examined in 4 cases of tumor lesions and their cell lines of human squamous cell carcinoma (SCC) of the oral cavity. The amplification was detected in 1 case (ZA), but not signifi